(19)
(11) EP 4 048 679 A1

(12)

(43) Date of publication:
31.08.2022 Bulletin 2022/35

(21) Application number: 20790017.6

(22) Date of filing: 19.10.2020
(51) International Patent Classification (IPC): 
C07F 9/655(2006.01)
A61K 31/662(2006.01)
A61K 31/665(2006.01)
 A61P 31/04(2006.01)
A61K 9/00(2006.01)
A61K 47/18(2017.01)
(52) Cooperative Patent Classification (CPC):
C07F 9/65515; A61P 31/04; A61K 31/665; A61K 9/0019; A61K 47/183
(86) International application number:
PCT/EP2020/079411
(87) International publication number:
WO 2021/078695 (29.04.2021 Gazette 2021/17)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 24.10.2019 EP 19205194

(71) Applicant: SANDOZ AG
4056 Basel (CH)

(72) Inventors:
  • LI, Jun
    6250 Kundl (AT)
  • IMLER, Josef
    6250 Kundl (AT)
  • RANEBURGER, Johannes
    6250 Kundl (AT)

(74) Representative: Prüfer & Partner mbB Patentanwälte · Rechtsanwälte 
Sohnckestraße 12
81479 München
81479 München (DE)

   


(54) NEW FORMULATIONS OF FOSFOMYCIN WITH REDUCED SODIUM CONTENT FOR PARENTERAL USE AND METHODS OF PRODUCING THE SAME